Navigating diagnostic challenges: E. coli-derived recombinant human bone morphogenetic protein-2 (rhBMP-2) induced endplate osteolysis and delayed spondylodiscitis: a case report
{{output}}
Background: Escherichia coli (E. coli)-derived recombinant human bone morphogenetic protein-2 (rhBMP-2) (NOVOSIS®, CGbio, Inc., Seoul, Republic of Korea) is increasingly used in selected spinal fusion surgeries to promote bony f... ...
